Tirzepatide (Mounjaro/Zepbound) Clinics in Philadelphia, Pennsylvania

34 Philadelphia, Pennsylvania clinic listings include Tirzepatide (Mounjaro/Zepbound) in their listed services. A listing tells you where to ask first; prescribing is the clinician's decision after an evaluation. 11 of these listings say they accept insurance, which covers the visit and does not confirm medication coverage.

Tirzepatide (Mounjaro/Zepbound) programs in Philadelphia typically cost between $377 and $816 per month. Prices depend on dosage, whether you use branded or compounded versions, and your insurance coverage. Pennsylvania Medicaid may help cover costs for eligible patients.

Yes. 11 tirzepatide providers serving Philadelphia offer telehealth consultations. Pennsylvania permits telehealth prescribing for GLP-1 medications by state-licensed providers. Both audio-visual and audio-only consultations are acceptable for follow-up visits. You can complete your consultation via video call and have medication shipped to your home.

Yes. Pennsylvania Medicaid covers GLP-1 medications including tirzepatide. Coverage details and prior authorization requirements vary by plan. Contact your Medicaid provider to verify tirzepatide is on your formulary.

Yes. Mounjaro and Zepbound (brand names for tirzepatide) are FDA-approved for weight management. Your provider will determine the right dosage based on your health history and goals.